Related Projects

The Horizon 2020 STARSTEM project combines nanotechnology, photoacoustic imaging and regenerative medicine. The project is developing gold nano-star particles, which are embedded in stem cells used for regenerative medicine treatments. The nano-stars are used as effective contrast agent for MSOT imaging, making the photo-acousting imaging more sensitive, and allowing to detect very small quantities at great depth under the skin. The project will use gold-enhanced contrast agents to monitor and better understand how stem cell therapies for arthritis actually work.

EUPHORIA is a project funded by the European Commission under the Fast Track to Innovation – a programme that enables excellent scientific research to make the transition to the market and the clinic.

EUPHORIA takes a novel imaging technology – Multi-Spectral Optoacoustic Tomography, or MSOT – and improves both its sensitivity and its effectiveness. It then demonstrates how well this enhanced technology can be used in the management of Inflammatory Bowel Disease (IBD).

The CleanAir project relates to the application of an innovative and novel geometrically extended electrode design to be integrated in air ionizers. The project aim is to develop this technology to a market-ready and CE mark certified device for series production for protecting health practitioners and their patients against COVID-19 infections. Market ready devices for three application areas will be preferentially developed in the project: for dental treatment rooms, for medical doctors offices and for patients rooms in a hospital.

Digital health technologies addressing the pandemic

Thirteen projects which have digital tools and Artificial Intelligence at the heart of their innovative approaches will deliver new solutions to protect healthcare workers, quickly detect and prevent the spread of COVID-19, and improve intensive care – all to contribute to the fight against the COVID-19 pandemic. Within the next 24 months, these projects, with a total funding of € 55.2 million, will deliver solutions in four complementary areas, with planned first prototypes being available in the coming 6 to 12 months.